The Mexican healthtech PROSPERiA announced it raised $2M in a seed round led by the Swedish fund Cardo Health.
PROSPERiA is a social impact initiative that wants to massify the early detection and treatment of chronic diseases through solutions based on Artificial Intelligence. Chronic diseases are responsible for three-quarters of all deaths worldwide.
In Latin America, the chronic diseases that have the greatest impact in number of deaths and as a cause of disability are diabetes mellitus, hypertension and cardiovascular diseases. PROSPERiA’s solution promotes the prevention and early diagnosis of these diseases through the development of risk assessment systems.
The tool works by creating and using an algorithm in the application of AI-based risk calculators that estimate a patient’s risk of diabetes and hypertension-related diseases. The solutions developed by the company have been used to evaluate 10,000 patients and detect over 4,500 potential pathologies.
The healthtech industry in Latin America still receives less funding than other sectors. Cristina Campero, CEO of PROSPERiA, explained that the company struggled to receive investments initially:
“Although Latin America has seen a boom in investment in recent years, 74 percent of this investment has been focused on four sectors: fintech, proptech, logistics, and e-commerce. Investment in healthcare represents less than 7 percent of all the investment Latin America has received in recent years, lagging behind the sector a little.”
Campero also shared PROSPERiA’s future plans:
“What we want to do with this investment is to boost the growth that we have had in recent months and reach our goal for 2022, which is to see 10,000 patients per month throughout the country and not just in Mexico City.”
